Anika Therapeutics, Inc. Operating Lease, Payments
Anika Therapeutics, Inc. (ANIK) reported Operating Lease, Payments of $1.98 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-06.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2020-03-06
- Anika Therapeutics, Inc. operating lease, payments for the quarter ending 2019-12-31 was $498.00K.
- Anika Therapeutics, Inc. operating lease, payments for the quarter ending 2019-09-30 was $488.00K.
- Anika Therapeutics, Inc. operating lease, payments for the quarter ending 2019-06-30 was $497.00K.
- Anika Therapeutics, Inc. operating lease, payments for the quarter ending 2019-03-31 was $497.00K.
- Anika Therapeutics, Inc. operating lease, payments for fiscal 2019 was $1.98M.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2019-12-31 | $498.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-06 | $986.00K derived: sum of 2 quarters · filed 2020-03-06 | $1.48M derived: sum of 3 quarters · filed 2020-03-06 | $1.98M 10-K · filed 2020-03-06 |
| 2019-09-30 | $488.00K 10-Q · filed 2019-10-28 | $985.00K derived: sum of 2 quarters · filed 2019-10-28 | $1.48M 10-Q · filed 2019-10-28 | |
| 2019-06-30 | $497.00K 10-Q · filed 2019-07-26 | $994.00K 10-Q · filed 2019-07-26 | ||
| 2019-03-31 | $497.00K 10-Q · filed 2019-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |